openPR Logo
Press release

Global Antibody Drug Conjugates Market Insights, Forecast

04-18-2019 07:42 PM CET | Health & Medicine

Press release from: Market Density

Global Antibody Drug Conjugates Market Insights, Forecast

Antibody Drug Conjugates are highly effective biopharmaceutical medications designed as a targeted therapy for cancer treatment. The preparation process of ADC’s involves great difficulty, inspite of these hurdles recently approved ADC’s have proved their worth for treatment of cancer. Thus, there is a strong pipeline of ADC’s that promises revolutionary changes in area of targeted therapy for cancer treatment. This market is driven by elements such as continuous improvement in the clinical data and technological advancements in the field of drug development shelling out innovative drugs into the market. The global Antibody Drug Conjugates market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Antibody Drug Conjugates market based on company, product type, end user and key regions. This report studies the global market size of Antibody Drug Conjugates in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Antibody Drug Conjugates in these regions. This research report categorizes the global Antibody Drug Conjugates market by top players/brands, region, type and end user. This report also studies the global Antibody Drug Conjugates market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors. The following manufacturers are covered in this report, with sales, revenue, market share for each company: F. Hoffman-La Roche Novartis AG Takeda Pharmaceutical Pfizer Seattle Genetics Genentech Immunogen Progenics Pharmaceuticals Bayer Healthcare Pharmaceuticals Market size by Product Adcetris Kadcyla Market size by End User Breast Cancer Lymphoma Market size by Region North America United States Canada Mexico Asia-Pacific China India Japan South Korea Australia Indonesia Singapore Malaysia Philippines Thailand Vietnam Europe Germany France UK Italy Spain Russia Central & South America Brazil Rest of Central & South America Middle East & Africa GCC Countries Turkey Egypt South Africa The study objectives of this report are: To study and analyze the global Antibody Drug Conjugates market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025. To understand the structure of Antibody Drug Conjugates market by identifying its various subsegments. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). Focuses on the key global Antibody Drug Conjugates companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development. To project the value and sales volume of Antibody Drug Conjugates submarkets, with respect to key regions. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. In this study, the years considered to estimate the market size of Antibody Drug Conjugates are as follows: History Year: 2014-2018 Base Year: 2018 Estimated Year: 2019 Forecast Year 2019 to 2025 This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Antibody Drug Conjugates market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources. For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Get sample copy of the report:

https://www.marketdensity.com/contact?ref=Sample&reportid=119233

Table of Contents:

Table of Contents

1 Study Coverage
1.1 Antibody Drug Conjugates Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Antibody Drug Conjugates Market Size Growth Rate by Product
1.4.2 Adcetris
1.4.3 Kadcyla
1.5 Market by End User
1.5.1 Global Antibody Drug Conjugates Market Size Growth Rate by End User
1.5.2 Breast Cancer
1.5.3 Lymphoma
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Antibody Drug Conjugates Market Size
2.1.1 Global Antibody Drug Conjugates Revenue 2014-2025
2.1.2 Global Antibody Drug Conjugates Sales 2014-2025
2.2 Antibody Drug Conjugates Growth Rate by Regions
2.2.1 Global Antibody Drug Conjugates Sales by Regions
2.2.2 Global Antibody Drug Conjugates Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Antibody Drug Conjugates Sales by Manufacturers
3.1.1 Antibody Drug Conjugates Sales by Manufacturers
3.1.2 Antibody Drug Conjugates Sales Market Share by Manufacturers
3.1.3 Global Antibody Drug Conjugates Market Concentration Ratio (CR5 and HHI)
3.2 Antibody Drug Conjugates Revenue by Manufacturers
3.2.1 Antibody Drug Conjugates Revenue by Manufacturers (2014-2019)
3.2.2 Antibody Drug Conjugates Revenue Share by Manufacturers (2014-2019)
3.3 Antibody Drug Conjugates Price by Manufacturers
3.4 Antibody Drug Conjugates Manufacturing Base Distribution, Product Types
3.4.1 Antibody Drug Conjugates Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antibody Drug Conjugates Product Type
3.4.3 Date of International Manufacturers Enter into Antibody Drug Conjugates Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Antibody Drug Conjugates Sales by Product
4.2 Global Antibody Drug Conjugates Revenue by Product
4.3 Antibody Drug Conjugates Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Antibody Drug Conjugates Breakdown Data by End User

6 North America
6.1 North America Antibody Drug Conjugates by Countries
6.1.1 North America Antibody Drug Conjugates Sales by Countries
6.1.2 North America Antibody Drug Conjugates Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Antibody Drug Conjugates by Product
6.3 North America Antibody Drug Conjugates by End User

7 Europe
7.1 Europe Antibody Drug Conjugates by Countries
7.1.1 Europe Antibody Drug Conjugates Sales by Countries
7.1.2 Europe Antibody Drug Conjugates Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Antibody Drug Conjugates by Product
7.3 Europe Antibody Drug Conjugates by End User

8 Asia Pacific
8.1 Asia Pacific Antibody Drug Conjugates by Countries
8.1.1 Asia Pacific Antibody Drug Conjugates Sales by Countries
8.1.2 Asia Pacific Antibody Drug Conjugates Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Antibody Drug Conjugates by Product
8.3 Asia Pacific Antibody Drug Conjugates by End User

9 Central & South America
9.1 Central & South America Antibody Drug Conjugates by Countries
9.1.1 Central & South America Antibody Drug Conjugates Sales by Countries
9.1.2 Central & South America Antibody Drug Conjugates Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Antibody Drug Conjugates by Product
9.3 Central & South America Antibody Drug Conjugates by End User

10 Middle East and Africa
10.1 Middle East and Africa Antibody Drug Conjugates by Countries
10.1.1 Middle East and Africa Antibody Drug Conjugates Sales by Countries
10.1.2 Middle East and Africa Antibody Drug Conjugates Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Antibody Drug Conjugates by Product
10.3 Middle East and Africa Antibody Drug Conjugates by End User

11 Company Profiles
11.1 F. Hoffman-La Roche
11.1.1 F. Hoffman-La Roche Company Details
11.1.2 Company Business Overview
11.1.3 F. Hoffman-La Roche Antibody Drug Conjugates Sales, Revenue and Gross Margin (2014-2019)
11.1.4 F. Hoffman-La Roche Antibody Drug Conjugates Products Offered
11.1.5 F. Hoffman-La Roche Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Company Details
11.2.2 Company Business Overview
11.2.3 Novartis AG Antibody Drug Conjugates Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Novartis AG Antibody Drug Conjugates Products Offered
11.2.5 Novartis AG Recent Development
11.3 Takeda Pharmaceutical
11.3.1 Takeda Pharmaceutical Company Details
11.3.2 Company Business Overview
11.3.Takeda Pharmaceutical Antibody Drug Conjugates Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Takeda Pharmaceutical Antibody Drug Conjugates Products Offered
11.3.5 Takeda Pharmaceutical Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Company Business Overview
11.4.3 Pfizer Antibody Drug Conjugates Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Pfizer Antibody Drug Conjugates Products Offered
11.4.5 Pfizer Recent Development
11.5 Seattle Genetics
11.5.1 Seattle Genetics Company Details
11.5.2 Company Business Overview
11.5.3 Seattle Genetics Antibody Drug Conjugates Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Seattle Genetics Antibody Drug Conjugates Products Offered
11.5.5 Seattle Genetics Recent Development
11.6 Genentech
11.6.1 Genentech Company Details
11.6.2 Company Business Overview
11.6.3 Genentech Antibody Drug Conjugates Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Genentech Antibody Drug Conjugates Products Offered
11.6.5 Genentech Recent Development
11.7 Immunogen
11.7.1 Immunogen Company Details
11.7.2 Company Business Overview
11.7.3 Immunogen Antibody Drug Conjugates Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Immunogen Antibody Drug Conjugates Products Offered
11.7.5 Immunogen Recent Development
11.8 Progenics Pharmaceuticals
11.8.1 Progenics Pharmaceuticals Company Details
11.8.2 Company Business Overview
11.8.3 Progenics Pharmaceuticals Antibody Drug Conjugates Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Progenics Pharmaceuticals Antibody Drug Conjugates Products Offered
11.8.5 Progenics Pharmaceuticals Recent Development
11.9 Bayer Healthcare Pharmaceuticals
11.9.1 Bayer Healthcare Pharmaceuticals Company Details
11.9.2 Company Business Overview
11.9.3 Bayer Healthcare Pharmaceuticals Antibody Drug Conjugates Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Bayer Healthcare Pharmaceuticals Antibody Drug Conjugates Products Offered
11.9.5 Bayer Healthcare Pharmaceuticals Recent Development

12 Future Forecast
12.1 Antibody Drug Conjugates Market Forecast by Regions
12.1.1 Global Antibody Drug Conjugates Sales Forecast by Regions 2019-2025
12.1.2 Global Antibody Drug Conjugates Revenue Forecast by Regions 2019-2025
12.2 Antibody Drug Conjugates Market Forecast by Product
12.2.1 Global Antibody Drug Conjugates Sales Forecast by Product 2019-2025
12.2.2 Global Antibody Drug Conjugates Revenue Forecast by Product 2019-2025
12.3 Antibody Drug Conjugates Market Forecast by End User
12.4 North America Antibody Drug Conjugates Forecast
12.5 Europe Antibody Drug Conjugates Forecast
12.6 Asia Pacific Antibody Drug Conjugates Forecast
12.7 Central & South America Antibody Drug Conjugates Forecast
12.8 Middle East and Africa Antibody Drug Conjugates Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antibody Drug Conjugates Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Browse this report online:

https://www.marketdensity.com/global-antibody-drug-conjugates-market-insights-forecast

About Market Density:

Market Density is your one stop market research and industry analysis reports' library providing business data and intelligence information on thousands of micro markets with global as well as regional coverage.
Market Density offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Market Density understands how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:

Email: sales@marketdensity.com

Website: www.marketdensity.com

Phone: +1 669 264 1656

4340 Stevens Creek Blvd,, Suite # 172,, San Jose, CA 95129

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Antibody Drug Conjugates Market Insights, Forecast here

News-ID: 1709960 • Views: 440

More Releases from Market Density

Global Product Management Software Market Size, Status and Forecast
This report focuses on the global Product Management Software status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Product Management Software development in United States, Europe and China. In 2017, the global Product Management Software market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025. The key players
Global Computer Aided Engineering (CAE) Market Size, Status and Forecast
This report focuses on the global Computer Aided Engineering (CAE) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Computer Aided Engineering (CAE) development in United States, Europe and China. Computer-aided engineering is the broad usage of computer software to aid in engineering analysis tasks. In regard to information networks, CAE systems are individually considered a single node on a total information
Global Computerized Numerical Control Market Size, Status and Forecast
This report focuses on the global Computerized Numerical Control status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Computerized Numerical Control development in United States, Europe and China. Computer numerical control (CNC) is the automation of machine tools by means of computers executing pre-programmed sequences of machine control commands. The key factor contributing to the computerized numerical control market is the growth
Global Connected Retail Market Size, Status and Forecast
This report focuses on the global Connected Retail status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Connected Retail development in United States, Europe and China. A Connected Retail strategy allows people to use the strength of the network to connect the brands to today's consumers. Connected Retail can help collaborate more effectively with employees and field managers, maintain security vigilance and

All 5 Releases


More Releases for Antibody

Global Antibody Production Market Analysis (2020-2025)
Global Info Research offers a latest published report on Antibody Production Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Antibody Production Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/reports/270141/antibody-production Market
Procalcitonin Antibody Market Opportunity Analysis, 2018 - 2026
Procalcitonin (PCT) is a peptide precursor of the hormone calcitonin, and belongs to calcitonin (CT) superfamily of peptides. Procalcitonin is a 116 amino acid peptide that has an estimated molecular weight of 14.5 kDa. It can be segregated into three parts, namely immature calcitonin, calcitonin carboxyl-terminus peptide-1, and amino terminus of the PCT region. Procalcitonin was first classified by Bernard Roos and Leonard J. Deftos in the early 1970s. Procalcitonin
Procalcitonin Antibody Market
Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E.coli Scope of the Report: This report focuses on the Procalcitonin
Antibody Drug Conjugate Market Opportunity Analysis
Ever since the first attempt in the 1980's to use antibody-based drugs as therapeutic agents, the application and use of monoclonal antibody-drug conjugates has evolved in several ways. The major advantage of using Antibody Drug Conjugates (ADC) is that it brings together the best characteristics of both antibodies and the cytotoxic potential of chemotherapy. This offers significant opportunity for the future in terms of targeted accumulation of drug in the
Global Antibody Drug Conjugate Market & Pipeline Insight2020
Pharmaceutical companies are trying to develop better therapeutics in order to overcome large unmet medical necessities. Currently available therapeutics suffers from various caveats like low specificity, low potency and severe adverse effects. This scenario has caused the pharmaceutical companies to develop therapeutics that can succeed these limitations. They have been able to overcome these problems and improve their medical conditions by commercializing ADC. They are rapidly gaining acceptance across the
Antibody Labeling Company Launch New Antibody Purification Range
Innova Biosciences announce the launch of their new antibody purification range AbSelect™ to compliment their successful antibody labeling technology Lightning-Link™. Cambridge, UK, March 31, 2011 - Innova Biosciences announce the launch of their new antibody purification range AbSelect™ to compliment their successful antibody labeling technology Lightning-Link™. Due to the benefits of direct immunodetection associated with their Lightning Link range, they have seen significant increases in sales of their simple, 30 seconds